- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06007599
Wound Healing in Primary TKA
August 17, 2023 updated by: Rothman Institute Orthopaedics
Surgical Wound Healing With and Without the Use of Skin Adhesive in Primary TKA
Wound complications after total knee arthroplasty (TKA) can arise from many patient-specific factors, such as vascular or immune-related medical conditions, obesity, and smoking, among others.
The development of early wound complications can lead to increased length of hospital stay and more serious complications, including deep infection and major subsequent surgery.
However, there are modifiable variables that could affect the risk of getting wound complications, such as the closure technique.
This study aims to analyze the difference in rates of wound complications using two different closure techniques in primary TKA.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
216
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19107
- Rothman Orthopaedic Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Patients older than 18 years old that will undergo primary TKA with a midline approach
Exclusion Criteria:
- Previous knee arthroplasty surgeries or midline scars
- TKA secondary to oncologic or traumatic etiologies
- BMI ≥ 40
- uncontrolled diabetes (measured by a Hgb A1c above 8)
- reported allergy to skin adhesive
- immunodeficiencies
- bleeding disorders
- anticoagulation other than ASA
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Group A: suture with skin adhesive
After surgery the closure technique utilized by the surgeons will be subcuticular running 3-0 monocryl sutures without skin adhesive
|
Wound closure using subcuticular running 3-0 monocryl sutures with skin adhesive
|
Active Comparator: Group B: suture without skin adhesive
After surgery the closure technique utilized by the surgeons will be subcuticular running 3-0 monocryl sutures with skin adhesive.
|
Wound closure using subcuticular running 3-0 monocryl sutures without skin adhesive
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
wound complications
Time Frame: 90 days
|
Assessed using Photographic documentation of the wound
|
90 days
|
Patient satisfaction
Time Frame: 90 days
|
Assessed using the POSAS (patient and observer scar assessment scale) questionnaire
|
90 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 16, 2023
Primary Completion (Estimated)
October 30, 2024
Study Completion (Estimated)
October 30, 2024
Study Registration Dates
First Submitted
August 17, 2023
First Submitted That Met QC Criteria
August 17, 2023
First Posted (Actual)
August 23, 2023
Study Record Updates
Last Update Posted (Actual)
August 23, 2023
Last Update Submitted That Met QC Criteria
August 17, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MAUS2023-2092
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Total Knee Replacement
-
Central DuPage HospitalTerminatedTotal Knee Replacement | Replacement, Total Knee | Arthroplasty, Knee ReplacementUnited States
-
Ottawa Hospital Research InstituteThe Ottawa Hospital Academic Medical AssociationCompletedTotal Hip Replacement | Total Knee ReplacementCanada
-
Singapore General HospitalCompletedTotal Knee Arthroplasty | Total Knee ReplacementSingapore
-
Istanbul UniversityCompleted
-
Istanbul UniversityCompletedTotal Knee Arthroplasty | Total Knee ReplacementTurkey
-
Mayo ClinicStryker OrthopaedicsCompletedArthroplasty, Replacement, Knee | Total Knee ReplacementUnited States
-
University of North Carolina, Chapel HillNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedKnee Arthroplasty, Total | Knee Replacement, TotalUnited States
-
Mayo ClinicCompletedKnee Total Joint Replacement | Hip Total Joint ReplacementUnited States
-
Isfahan University of Medical SciencesCompletedTotal Knee Replacement | Total Knee Arthroplasty(TKA)Iran, Islamic Republic of
-
Assiut UniversityNot yet recruitingTotal Knee Replacement
Clinical Trials on Skin closure using skin adhesive
-
Rothman Institute OrthopaedicsEnrolling by invitation
-
The University of Texas Health Science Center,...TerminatedEyelid LacerationUnited States
-
Wake Forest University Health SciencesTerminated
-
Pooriwat LertsurawatKittipon NaratrikunActive, not recruiting
-
Children's Mercy Hospital Kansas CityCompletedThe Role of 2-octyl Cyanoacrylate in Prevention of Recurrent Adhesions After Circumcision (Circglue)Adhesions | PhimosisUnited States
-
Center for Innovation and Research OrganizationSuspended
-
Cairo UniversityCompletedCesarean Section WoundEgypt
-
Reinier Haga Orthopedisch CentrumNot yet recruiting
-
First Affiliated Hospital, Sun Yat-Sen UniversityUnknownGastric Cancer | Colorectal Cancer | Surgical Site Infection | Inflammatory Bowel Disease | Gastrointestinal Stromal Tumor | Diverticula | Complications of Surgical ProceduresChina